Search results
Results from the WOW.Com Content Network
In 2005, Abiomed purchased ventricular assist device company Impella CardioSystems AG of Aachen, Germany, [11] maker of the Impella heart pump, developed by Thorsten Siess, [12] who is now the chief technology officer at Abiomed. [13] [self-published source] After Abiomed acquired Impella the company's focus shifted from heart replacement to ...
Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide left heart support during other forms of mechanical circulatory support including ECMO and Centrimag.
Johnson & Johnson struck a massive $16.6 billion all-cash deal in 2022 to buy Abiomed to boost growth in its medical devices unit. Abiomed operates as a standalone business under J&J's MedTech unit.
Impella, part of a family of invasive heart pump devices manufactured by Abiomed, provides circulatory support to patients who develop left side ventricular failure and is authorized to be used by ...
Abiomed's (ABMD) flagship Impella heart pump line is a major growth driver. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...
Abiomed's (ABMD) Impella RP with SmartAssist gets the highest level of approval from the FDA for treatment of right heart failure.
Abiomed (ABMD) has announced that the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading ...
Additionally, the AbioCor product has been removed from the AbioMed website, with several news agencies reporting in 2015 that the company had quietly abandoned further development of the device. [6] [7] In 2019, Abiomed was marketing the Impella Ventricular Support Systems, left-side heart pump models "intended to help pump blood in patients ...